| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | IMMUNOMEDICS INCORPORATED | 10,488,076 | 67,858,000 | 8.67% | ||
| 2 | TESARO INCORPORATED | 411,823 | 63,367,000 | 8.09% | ||
| 3 | MEDICINES CO | 1,185,000 | 57,947,000 | 7.40% | ||
| 4 | ACADIA PHARMACEUTICALS INC COM | 1,630,000 | 56,039,000 | 7.16% | ||
| 5 | BIOMARIN PHARMACEUTICAL INC | 590,000 | 51,790,000 | 6.62% | ||
| 6 | DERMIRA INC COM | 1,202,313 | 41,011,000 | 5.24% | ||
| 7 | AMICUS THERAPEUTICS INC COM | 4,847,577 | 34,563,000 | 4.42% | ||
| 8 | LION BIOTECHNOLOGIES INC COM | 4,551,343 | 33,908,000 | 4.33% | ||
| 9 | ARRAY BIOPHARMA INC | 3,780,000 | 33,793,000 | 4.32% | ||
| 10 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 815,000 | 30,033,000 | 3.84% | ||
| 11 | TELIGENT INC NEW | 3,791,512 | 29,612,000 | 3.78% | ||
| 12 | SEATTLE GENETICS INC | 450,000 | 28,287,000 | 3.61% | ||
| 13 | CLOVIS ONCOLOGY INC | 353,900 | 22,533,000 | 2.88% | ||
| 14 | Ascendis Pharma | 700,924 | 19,626,000 | 2.51% | ||
| 15 | AERIE PHARMACEUTICALS INC COM | 425,000 | 19,274,000 | 2.46% | ||
| 16 | PACIRA PHARMACEUTICALS INC | 410,000 | 18,696,000 | 2.39% | ||
| 17 | ASSEMBLY BIOSCIENCES INC | 696,409 | 17,751,000 | 2.27% | ||
| 18 | AVEXIS INC COM | 225,370 | 17,135,000 | 2.19% | ||
| 19 | NEURODERM LTD | 590,000 | 15,665,000 | 2.00% | ||
| 20 | BIOCRYST PHARMACEUTICALS | 1,603,001 | 13,465,000 | 1.72% | ||
| 21 | AGENUS INC | 3,368,828 | 12,700,000 | 1.62% | ||
| 22 | MIRATI THERAPEUTICS INC COM | 2,383,201 | 12,393,000 | 1.58% | ||
| 23 | VANDA PHARMACEUTICALS INC COM | 617,200 | 8,641,000 | 1.10% | ||
| 24 | VERACYTE INC | 906,999 | 8,326,000 | 1.06% | ||
| 25 | ALIMERA SCIENCES INC | 5,791,581 | 8,108,000 | 1.04% | ||
| 26 | CASCADIAN THERAPEUTICS INC | 1,821,248 | 7,540,000 | 0.96% | ||
| 27 | CATALYST PHARMACEUTICALS INC | 3,804,745 | 7,419,000 | 0.95% | ||
| 28 | BLUEPRINT MEDICINES CORP COM | 165,000 | 6,598,000 | 0.84% | ||
| 29 | Axovant Sciences LTD | 384,587 | 5,746,000 | 0.73% | ||
| 30 | VIVEVE MED INC COM NEW | 890,000 | 5,634,000 | 0.72% | ||
| 31 | SORRENTO THERAPEUTICS INC COM NEW | 1,192,130 | 4,709,000 | 0.60% | ||
| 32 | AKEBIA THERAPEUTICS INC | 456,369 | 4,199,000 | 0.54% | ||
| 33 | FORTRESS BIOTECH INC | 996,663 | 3,688,000 | 0.47% | ||
| 34 | CORVUS PHARMACEUTICALS INC COM | 121,715 | 2,528,000 | 0.32% | ||
| 35 | CELLECTIS S A | 97,096 | 2,330,000 | 0.30% | ||
| 36 | AVEO PHARMACEUTICALS INC | 3,938,030 | 2,323,000 | 0.30% | ||
| 37 | ONCOBIOLOGICS INC | 683,531 | 1,832,000 | 0.23% | ||
| 38 | PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | 1,651,000 | 0.21% | PRN | |
| 39 | BELLICUM PHARMACEUTICALS INCORPORATED | 125,000 | 1,543,000 | 0.20% | ||
| 40 | TRILLIUM THERAPEUTICS INC | 227,399 | 1,399,000 | 0.18% | ||
| 41 | ARRAY BIOPHARMA INC | 861,400 | 390,000 | 0.05% | Call | |
| 42 | CLOVIS ONCOLOGY INC | 125,800 | 258,000 | 0.03% | Call | |
| 43 | AMICUS THERAPEUTICS INC COM | 250,000 | 206,000 | 0.03% | Call | |
| 44 | ONCOBIOLOGICS INC - WARRANT A | 233,333 | 187,000 | 0.02% | ||
| 45 | ONCOBIOLOGICS INC - WARRANT B | 233,333 | 117,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-027247, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
